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Purpose. Previously, we have shown that complexes of plasmid DNA with the biodegradable polymer
poly(2-dimethylamino ethylamino)phosphazene (p(DMAEA)-ppz) mediated tumor selective gene
expression after intravenous administration in mice. In this study, we investigated the effect of
p(DMAEA)-ppz molecular weight on both in vitro and in vivo tumor transfection, as well as on complex
induced toxicity.
Materials and Methods. p(DMAEA)-ppz with a broad molar mass distribution was fractionated by
preparative size exclusion chromatography. Polyplexes consisting of plasmid DNA and the collected
polymer fractions were tested for biophysical properties, (cyto)toxicity and transfection activity.
Results. Four p(DMAEA)-ppz fractions were collected with weight average molecular weights ranging
from 130 to 950 kDa, and with narrow molecular mass distributions (Mw/Mn from 1.1 to 1.3). At
polymer-to-DNA (N/P) ratios above 6, polyplexes based on these polymers were all positively charged
(zeta potential 25–29 mV), and had a size of 80–90 nm. The in vitro cytotoxicity of the polyplexes
positively correlated with polymer molecular weight. The in vitro transfection activity of the different
polyplexes depended on their N/P ratio, and was affected by the degree of cytotoxicity, as well as the
colloidal stability of the different polyplexes. Intravenous administration of polyplexes based on the high
molecular weight polymers led to apparent toxicity, as a result of polyplex-induced erythrocyte
aggregation. On the other hand, administration of polyplexes based on low molecular weight
p(DMAEA)-ppz_s( M w 130 kDa) did not show signs of toxicity and resulted in tumor selective gene
expression.
Conclusion. Polymer molecular weight fractionation enabled us to optimize the transfection efficiency/
toxicity ratio of p(DMAEA)-ppz polyplexes for in vitro and in vivo tumor transfection.
KEY WORDS: biodegradable; cationic polymer; DNA; molecular weight; tumor gene delivery.
INTRODUCTION
Non-viral gene delivery holds promise as a therapy against
cancer. The genes used for application in anticancer gene med-
icine encode for antigens, cytokines and suicide proteins (1). In
order to efficiently reach metastatic tumors, intravenous admin-
istration is the preferred route of administration. In this light,
cationic polymers can be useful. The condensation of plasmid
DNA using cationic polymers results in positively charged,
nanosized polyplexes with improved resistance againstnucleases
present in blood and other extracellular fluids. In addition,
positively charged polyplexes are readily taken up by the target
cells. Moreover, surface modification of polyplexes enables
improved circulation kinetics and tumor targeting. Indeed, the
application of polymers for cancer gene therapy so far has
resulted in tumor regression in several animal models (1,2).
Cationic polymers currently used for gene delivery are
mostly non-degradable and cytotoxic, limiting their wide-
spread use. The application of biodegradable polymers in
polyplexes is a means to prevent long-term polymer tissue ac-
cumulation and therefore limit toxicity (3). Ideally, the deg-
radation of the polymer will result in low molecular weight
fragments which will be subjected to glomerular kidney
filtration or will be metabolized (4). Recently, we reported
on the application of the biodegradable poly(2-dimethylamino
ethylamino)phosphazene (p(DMAEA)-ppz) for tumor gene
delivery (Fig. 1). It was shown that polyplexes based on
p(DMAEA)-ppz mediated gene expression to a similar extent
as linear polyethylenimine (PEI). Gene expression was con-
fined to the tumor tissue, whereas the use of PEI polyplexes
also resulted in substantial expression in non-target organs,
particularly in lungs, spleen and liver (5).
Biodegradable as well as non-biodegradable gene deliv-
ery polymers generally have a broad molecular weight dis-
tribution. Several studies have reported on the importance of
polymer molecular weight in the outcome of transfection (6–
17). From these studies, it appears that polymer molecular
weight not only affects the transfection efficiency of the
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Moreover, polymer molecular weight was found to affect the
pharmacokinetics of the polyplexes (9,13,14). For a better
understanding of how polymer molecular weight affects
transfection activity, these studies are of limited use as the
polymers were poorly characterized, had a broad molecular
weight distribution, or varied in additional characteristics like
branching and conjugation with shielding or targeting li-
gands. Moreover, several studies included only two different
molecular weights, or focused on parameters other than
transfection activity. To our knowledge, only few studies
have related polymer molecular weight and in vitro transfec-
tion activity, using a series of polymers with narrow
molecular weight distributions (18–21). None of these studies
addressed the additional issue of intravenous administration
and/or in vivo tumor transfection.
In this study, we used size exclusion chromatography to
fractionate a batch of p(DMAEA)-ppz with a broad molec-
ular weight distribution. We obtained four fractions with dif-
ferent molecular weights and relatively narrow molecular
weight distributions. Using these fractions, we were able to
assess the effect of polymer molecular weight on the trans-
fection efficiency/toxicity ratio of p(DMAEA)-ppz poly-
plexes for in vitro and in vivo tumor transfection.
MATERIALS AND METHODS
Materials
The plasmid used in this study, pcDNA3Luc, consists of
the coding region for firefly luciferase inserted in the plasmid
pcDNA3 (Invitrogen, UK) and is under the transcriptional con-
trol of the cytomegalovirus immediate promoter. Endotoxin-
free pcDNA3Luc was produced by Plasmid Factory (Bielefeld,
Germany). An ethidium bromide (EtBr) stock solution was
obtained from Sigma (Zwijndrecht, The Netherlands). Lucifer-
ase assay reagent, reporter gene lysis buffer, and Quantilum
recombinant luciferase were obtained from Promega (Leiden,
The Netherlands).
Polymer Synthesis
Poly(2-dimethylamino ethylamino)phosphazene
(p(DMAEA)-ppz) was synthesized and purified as previously
described (22,23). In brief, poly(dichloro)phosphazene was syn-
thesized from hexachlorocyclotriphosphazene at 250-Ci n
1,2,4, trichlorobenzene using sulfamic acid and CaSO42H2O
as an initiating system (24). Next, the formed poly(dichloro-
phosphazene) was substituted with 2-dimethylamino ethyl-
amine. The resulting polymer was purified by extensive
dialysis against water and THF, and the solvent was removed
under reduced pressure. Finally, the polymer was dissolved in
water and collected after freeze-drying.
Preparative SEC Fractionation
A batch of the starting polymer p(DMAEA)-ppz with a
broad molar mass distribution was fractionated using a size
exclusion chromatography (SEC) system. The SEC system
consisted of a Waters 600 EF pump, connected to a Waters
2700 sample manager.A semi-preparative column set(Shodex
OHpak SB-LG, OHpak SB-2006 M) was used. The eluent was
0.3M NaAc (pH 5.0) with a flow rateof 1.5ml/min. This eluent
suppresses ionic interactions between the polymer and the
stationary phase (25).
For each fractionation run, 500 ml of solution of
p(DMAEA)-ppz (10 mg/ml in eluent) was injected onto the
column. Ten fractions were collected at 2 min intervals. The
corresponding fractions from 400 repeated runs were pooled,
extensively dialyzed against water and collected after freeze-
drying. From the resulting ten fractions, two high molecular
weight fractions were selected (ppz950 and ppz570) and used
for experimental evaluations. Two fractions with intermedi-
ate molecular weight were dissolved, pooled and subjected to
a second fractionation, using the same SEC settings as de-
scribed above. To this end, five fractions were collected at
3 min intervals, dialyzed and freeze-dried. From the resulting
fractions, two low molecular weight fractions (ppz290 and
ppz130) were selected for further evaluations.
Characterization of the Polymer Fractions
The average molecular weights and the molecular weight
distribution of the fractionated polymers were determined by
SEC, using a Viscotek VE 2001 system (25). Two Shodex SB-
804 M columns with a pre-column (Shodex OH-pak SB-G)
were connected to a Triple Detector Array 302, equipped with
a low and a right angle light scattering detector, a viscometer
detector and a refractive index detector. The eluent was 0.3 M
NaAc (pH 4.4) with a flow-rate of 1.0 ml/min. The refractive
index increment (dn/dc) of p(DMAEA)-ppz was determined
by injecting p(DMAEA)-ppz solutions with different concen-
Fig. 1. Structure of poly(2-dimethylamino ethylamino)phosphazene
(p(DMAEA)-ppz).
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MolecularweightdataanalysiswasperformedbyOmniSEC4.1
software.
An
31P-Nuclear magnetic resonance (NMR) spectrum of
the fractionated polymers was recorded on a Varian Inova
500 MHz spectrometer (Varian, USA) (22).
Preparation of the Polyplexes
Plasmid DNA encoding for firefly luciferase (pcDNA3-
Luc)wasusedforallexperiments.Themolarpolymer-to-DNA
(N/P) ratio ofthe polyplexes varied from 1.5to100.A mass per
charge of 110 and 330 Da was used for p(DMAEA)-ppz and
DNA, respectively.
Polyplexes for the in vitro experiments were prepared at
a DNA concentration of 10 mg/ml. The buffers used for the
preparation of the polyplexes had either a low ionic strength
(5 mM Hepes, pH 7.4 or 20 mM Hepes, 5% g/v glucose, pH
7.4, HBG) or a high ionic strength (20 mM Hepes, 150 mM
NaCl, pH 7.4, HBS). Polyplexes were prepared by adding
four volumes of the polymer solution to one volume of the
DNA solution. The resulting dispersions were vortexed and
incubated for 30 min at room temperature before use (26).
Polyplexes for the in vivo studies, and for the in vitro
erythrocyte aggregation assays were prepared at a DNA
concentration of 150 mg/ml (20 mM Hepes, 5% g/v glucose,
pH 7.1) by adding one volume of a polymer solution to one
volume of DNA solution. The resulting dispersions were
vortexed and incubated for 30 min at room temperature.
Then, one tenth a volume of a 50% g/v D-glucose stock was
added to obtain iso-osmolarity (27).
Characterization of the Polyplexes
The average hydrodynamic diameter and the zeta-
potential of the polyplexes were determined using dynamic
light scattering and electrophoretic mobility measurements,
respectively, at a DNA concentration of 10 mg/ml. The size of
the polyplexes was determined using an ALV CGS-3 system
(Malvern Instruments, UK). The zeta-potential of the poly-
plexes was determined using a Zetasizer 2000 (Malvern
instruments, UK). Both instruments were calibrated using
polystyrene latex beads of defined size and zeta-potential.
Condensation of DNA by the polymers was determined
using an ethidium bromide (EtBr) fluorescence quenching
assay (28). EtBr was added to a DNA solution 10 min prior
to polyplex formation at a molar ratio of 1:8. Next, EtBr
labeled polyplexes were prepared at a DNA concentration of
10 mg/ml in Hepes or HBS, as described earlier. The resulting
fluorescence was quantified using a Fluorstar Optima plate-
reader (BMG Lab Tech, Germany). Fluorescence values
were measured at an excitation/emission wavelength of 500
and 600 nm, respectively, and converted into relative,
residual fluorescence (Fr) using the following equation:
Fr ¼ Fobs   Fe ðÞ = F0   Fe ðÞ ;
where Fobs istheobservedfluorescenceofthepolyplexsamples,
Fe is the fluorescence of EtBr in the absence of DNA, and F0
is the fluorescence of EtBr in the presence of DNA.
In Vitro Transfection
Neuro 2 A (Murine Neuroblastoma) cells (ATCC CCL-
131) were cultured in RPMI 1640 medium completed with
bovinecalfserum(10%)andantibiotics/antimycotics(100U/ml
penicillin, 100 mg/ml streptomycin, 0.25 mg/ml amphotericin B)
at 37-C at a 5% CO2 humidified atmosphere.
Transfection and cytotoxicity studies were carried out in
serumcontainingmedium,asdescribedearlier(5). In brief, cells
were seeded in a 96-well plate at a density of 1 10
4 cells/well.
After twenty-four hours, cells were overlaid with fresh medium
(100 ml) and subsequently overlaid with a polyplex dispersion
(100 ml, 1 mg DNA, HBS or HBG). Cells were incubated with
the polyplexes for 1 h. Subsequently, the medium was
refreshed and the cells were cultured for another 24 h. All
transfection experiments were carried out in duplicate in two
separate 96-well plates. One series was tested for reporter gene
expression (luciferase activity) (5), the other series was tested
for cell viability using an XTT colorimetric assay (29).
Luciferase activity was measured after lysis of the cell
pellet by the addition of 100 ml reporter gene lysis buffer fol-
lowed by a single freeze/thaw cycle. Luciferase activity of the
samples was determined using a Berthold 9507 Luminometer
(EG&G Benelux BV, The Netherlands) by mixing 20 mlo f
the defrosted cell lysate with 100 ml of luciferase assay reagent.
Relative light units (RLU) were measured for 10 s at room
temperature and werecorrected for backgroundvalues.In this
setting, 6 10
3 RLUs corresponded to 1 pg of recombinant
luciferase.
The percentage of viable cells was tested using an XTT
colorimetric assay, based on the metabolic, cellular reduction
of a tetrazolium reagent (29). Cell viability values were nor-
malized to values obtained after incubation with buffer only.
Polyplex-induced Erythrocyte Aggregation
Mouse erythrocytes were isolated from heparinized
blood by centrifugation. The erythrocyte pellet was washed
several times with HBS buffer. Subsequently, a suspension
was prepared by diluting the erythrocyte pellet 40 times with
HBS. To 20 ml of the different polyplex dispersions (150 mg/ml
DNA in 20 mM Hepes, 5% g/v glucose, pH 7.1, N/P ratio 12),
230 ml of the erythrocyte suspension was added. After 1 h of
incubation at 37-C, aliquots of the suspensions were taken for
microscopic analysis (20 ).
In Vivo Gene Expression Studies
The animal experiments were performed according to
national regulations and approved by the local animal
experiments ethical committee. Six-week old male A/J mice
(Harlan, The Netherlands) were inoculated with 1 10
6
Neuro 2 A cells in the left flank. Eight to twelve days after
inoculation, at an average tumor volume of 0.4–0.8 cm
3, the
different polyplex dispersions were injected into the tail-vein
of the mice (0.2 ml, corresponding with 30 mg DNA). The
mice were sacrificed 24 h after injection by cervical dis-
location and luciferase levels of the different organs were
assessed as previously described (30). Briefly, organs were
homogenized in 0.5–1 ml of reporter gene lysis buffer, using a
tissue homogenizer. The tissue homogenates were incubated
1574 de Wolf et al.on ice for 30 min, then vortexed and subsequently centrifuged
at 12,000 g for 10 min. The luciferase activity of the samples
was determined using a Berthold 9507 Luminometer by
mixing 20 ml of the supernatant with 100 ml of luciferase assay
reagent. Relative light units (RLU) were measured for 10 s at
room temperature and were corrected for background values.
In this setting, 6 10
3 RLUs corresponded to 1 pg of re-
combinant luciferase. The transfection activity of the poly-
plexes was expressed as RLU/organ or RLU/tumor.
RESULTS AND DISCUSSION
Polymer Synthesis
Abatch ofpolymerp(DMAEA)-ppz wassynthesized and
purifiedas previously described (22). The SEC chromatogram
of this starting polymer is shown in Fig. 2a. The polymer had
a weight average molecular weight of 680 kDa (Table I). The
measured molecular weight distribution was around 2 and is
a consequence of the method of polymerization (22–24).
Fractionation
Aqueous size exclusion chromatography (SEC) was used
for fractionation and analysis of the p(DMAEA)-ppz poly-
mers. The combined, online use of a series of detectors (low
and right angle light scattering, viscosity, refractive index)
enabled the determination of the absolute molecular weight
of the fractionated polymers, as well as their molecular
weight distribution. The refractive index increment (dn/dc) of
p(DMAEA)-ppz was determined to be 0.159 ml/g.
Figure 2b shows the SEC chromatogram of one of the
fractions of p(DMAEA)-ppz (ppz290). The molecular weight
distribution of this fractionated polymer was relatively
narrow (Mw/Mn 1.2, Table I). The same held true for the
other fractionated polymers (Mw/Mn 1.1–1.3). The weight
average molecular weight of the different polymers ranged
from 130 to 950 kDa which corresponds to hydrodynamic radii
ranging from 8 to 26 nm. The dependency of the calculated
molecular weight on retention volume was found to be linear
for the different polymers, demonstrating good SEC separa-
tion conditions.
31P-NMR analysis of the selected fractions
showed one peak at 1.7 ppm (22) indicating that no polymer
degradation had occurred during the fractionation process.
Biophysical Characterization
Polyplexes with a mean size between 80 to 90 nm were
formed upon complexation of the different polymer fractions
with plasmid DNA at a relatively low DNA concentration
(10 mg/ml) and at low ionic strength (Hepes buffer),
independent of the polymer molecular weight (Table II).
All polyplexes had a positive surface charge (zeta-potential
25–29 mV). At high ionic strength (HBS), the different
polyplexes gradually aggregated. Most likely, aggregation
occurs due to the reduction in zeta-potential of the particles
which leads to a decrease in interparticle repulsion and
colloidal stability. Aggregate formation was observed over a
broad range of N/P ratios in the case of the polyplexes based
on the smaller molecular weight polymers (ppz290 and
ppz130), whereas the higher molecular weight polymers
showed aggregate formation only at N/P ratios of 3 to 6
(starting polymer, ppz950 and ppz570, Fig. 3). The low col-
loidal stability of the polyplexes based on the low molecular
weight polymers is in good agreement with earlier findings on
PEI, pLL, and pDMAEMA polyplexes (9,14,19). Probably,
the low molecular weight polymers have reduced DNA
condensation abilities, due to their reduced number of
electrostatic interactions, leading to intensified aggregation
at high ionic strength. At a relatively high DNA concentra-
tion and a low ionic strength (150 mg/ml DNA in HBG), again
small particles were formed, though the complexes were
somewhat bigger than formed at lower DNA concentration
(Table II).
The DNA binding ability of the different p(DMAEA)-
ppz_s was determined by measuring the fluorescence remain-
ing upon addition of the different polymers to EtBr labeled
Fig. 2. SEC chromatogram of the starting polymer (a) and polymer
fraction ppz290 (b). Left axis: low angle light scattering (bright grey),
viscosity (medium grey), refractive index (dark grey). Right axis:
calculated molar mass dependency (black).
Table I. Characterization of the Starting Polymer and the Obtained
Polymer Fractions
Fraction Mw (kDa) Mn (kDa) Mw/Mn Rh (nm)
Starting ppz 680 390 1.8 21
Ppz950 950 850 1.1 26
Ppz570 570 440 1.3 19
Ppz290 290 250 1.2 13
Ppz130 130 100 1.3 8
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ratios of 6 and higher, the extent of DNA binding was similar
for the different p(DMAEA)-ppz_s (20% of the original
fluorescence remaining). Complexation of DNA with the
starting polymer resulted in a considerably stronger DNA
binding (residual fluorescence 9–13%). At high ionic strength
(HBS), 50% of the original fluorescence was remaining after
incubation with the fractionated polymers (data not shown),
pointing to a reduced DNA binding capability. Also, the
starting polymer showed a lower DNA binding ability, albeit
stronger than the fractionated polymers (35% of the original
fluorescence remaining). The DNA binding observed for the
starting polymer, as reflected by the quenching of EtBr
fluorescence, is similar to values observed for linear PEI (Mw
22 kDa, PEI22). Mixing of the different p(DMAEA)-ppz
fractions in equal mass ratios yielded less EtBr quenching
than observed for the starting polymer. Most likely, a
particular molecular weight fraction with a high DNA
binding ability was present within the starting polymer and
is lost during fractionation.
Polyplex Cytotoxicity
Cytotoxicity of the different p(DMAEA)-ppz polyplexes
was determined using the XTT assay, by comparing the
cellular mitochondrial activity of the polyplex treated cells to
that of untreated cells. Figure 5 shows the relative cell
viability of Neuro 2 A cells, 24 h after transfection with the
polyplexes prepared at different N/P ratios. Cytotoxicity
positively correlated with polymer molecular weight, in good
agreement with earlier findings on PEI, PLL and other
polymers (8,12,19,31,32). Polyplexes based on the starting
polymer showed significant cytotoxicity, similar to polyplexes
based on the high molecular weight polymer fractions
(ppz950 and ppz570). Polyplexes based on PEI22 were found
to be equally cytotoxic as ppz290 based polyplexes, at the
different N/P ratios. At 48 h after transfection, a similar
molecular weight correlation was found (data not shown).
Recently, the mechanisms underlying the enhanced
cytotoxicity of 27 kDa PLL polyplexes was investigated, in
comparison to 2.9 kDa PLL polyplexes (12,33). The 27 kDa
PLL was found to initiate a stronger, early stage, cell mem-
brane perturbation than the low molecular weight polymer,
possibly as a result of the more extensive interactions with
the cell surface. Moreover, only the 27 kDa PLL and not the
2.9 kDa PLL induced a direct release of cytochrome C from
isolated mitochondria, a phenomenon related with late stage
cytotoxicity (12). Similar factors might underlie the enhanced
cytotoxicityobservedforthehighmolecularweightp(DMAEA)-
ppz_su s e di nt h i ss t u d y .
Table II. Mean Diameter (nm) and Zeta Potential (mV) of DNA/p(DMAEA)-ppz Complexes
10 mg DNA/ml, N/P 6 150 mg DNA/ml
Hepes or HBS Buffer HBG Buffer
Mean Zeta Potential Mean Diameter Mean Diameter Mean Diameter Mean Diameter Mean Diameter
Hepes Hepes HBS N/P 6 N/P 12 N/P 20
Starting Polymer 33T68 5 T4 770T250 175T0 162T20 N.D.
Ppz950 29T29 3 T7 170T12 226T13 195T10 N.D.
Ppz570 25T57 8 T1 330T13 182T16 128T4 N.D.
Ppz290 26T77 9 T3 >1,000 N.D. 152T13 158T10
Ppz130 28T18 4 T6 >1,000 N.D. 145T12 126T7
Polyplexes were measured after 1 h of incubation (meanTSD, n=3). Polydispersity values of the polyplexes were within acceptable limits (<0.3).
Fig. 3. Aggregation of DNA/p(DMAEA)-ppz complexes at high
ionic strength. Particle size of complexes based on the starting
polymer (circles) and ppz130 (diamonds), after 1 h of incubation in
HBS (20 mM Hepes, 150 mM NaCl, pH 7.4) (mean, n=3).
Fig. 4. DNA binding of p(DMAEA)-ppz polymers. DNA binding
was measured in Hepes buffer and quantified as percentage residual
fluorescence, 1 h after addition of polymer to EtBr labeled DNA
(meanTSD, n=3).
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The in vitro transfection activity of the different
p(DMAEA)-ppz polyplexes was investigated. Figure 6 shows
the luciferase expression by Neuro 2 A cells, 24 h after trans-
fection with the polyplexes prepared at different N/P ratios.
The maximum degree of gene expression was about two
orders of magnitude lower than that observed for polyplexes
based on PEI22 (N/P 6). Transfection with polyplexes based
on the 290 kDa p(DMAEA)-ppz resulted in a bell-shaped
curve with highest gene expression levels at N/P ratios of 6 to
50 (Fig. 6d) (19). At low N/P ratios, transfection activity is
low, as the polyplexes do not have the favorable physico-
chemical characteristics required for efficient cellular adhe-
sion, internalization, and a limited extent of (endosomal and
nuclear) membrane permeabilization activity (18,19,33). At
high N/P ratios, gene expression levels drop most likely due
to cytotoxic effects exerted by free, non-DNA associated
polymer. In the case of the lowest molecular weight polymer
(ppz130), gene expression levels only slightly decrease even
at high N/P ratios (Fig. 6e). The low cytotoxicity of the
polyplexes based on this polymer enables gene expression
even at these high N/P ratios. Transfection with polyplexes
based on the starting polymer and the highest molecular
weight fraction ppz950 resulted in reduced transfection activity
at the intermediate N/P ratios of 6 to 50. Likely, pronounced
cytotoxicityattheseN/Pratiosopposesthetransfectionprocess
(see polyplex cytotoxicity). Complexes based on ppz570
displayed a somewhat intermediate gene expression profile
(Fig. 6c).
Polyplexes based on the starting polymer and on ppz950
showed a striking maximum in transfection activity at an N/P
ratio of 3 (Fig. 6a and b). To study this phenomenon in more
detail, polyplexes based on the starting polymer were
prepared in transfection medium with high ionic strength
(HBS) and in transfection medium with low ionic strength
(HBG). In contrast to the polyplexes prepared in HBS, which
rapidly aggregated at N/P ratios of 3 to 6 (diameter 800 to
>1000 nm, see also Fig. 3), polyplexes prepared in HBG
remained small in time (diameter õ 100 nm at all N/P ratios
>1.5).TransfectionactivityoftheFHBS_aggregatedpolyplexes
was 15–25 fold higher than their non-aggregated counterparts
(Fig. 7). Most likely, complex aggregation in the transfection
medium (HBS) is the cause for the observed peak in
transfection activity (at N/P 3 to 6, Fig 6a). Earlier, aggregate
formation has been found to improve transfection efficiency,
likely due to complex sedimentation which enhances the cel-
lular contact and subsequent cellular internalization (34,35).
Therefore, likely, the polyplex aggregation observed for the dif-
Fig. 5. Cytotoxicity of DNA/p(DMAEA)-ppz complexes towards
Neuro 2 A cells, 24 h after incubation (meanTSD, n=3).
Fig. 6. In vitro gene expression of Neuro 2 A cells after transfection with DNA/p(DMAEA)-ppz complexes. Relative light units per well,
24 h after transfection (meanTSD, n=3).
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expression profiles, observed in Fig. 6.
Safety Aspects
Polyplex-induced erythrocyte aggregation is an impor-
tant factor determining the toxicity of polyplexes after
intravenous administration (36). The extent of erythrocyte
aggregation was studied, 1 h after incubation with the differ-
ent polyplexes (150 mg/ml DNA, size 130–230 nm, Table II).
At an N/P ratio of 12, the degree of erythrocyte aggregation
was found to correlate with the molecular weight of the poly-
mer used. Extensive aggregation was observed for polyplexes
based on the starting polymer and the high molecular weight
fractions (ppz950 and ppz570) (Fig. 8a–c). Incubation of the
erythrocytes with polyplexes based on the lower molecular
weight polymers (ppz290 and ppz130) clearly resulted in a
more limited erythrocyte aggregation (Fig. 8d and e). For all
polymers, the extent of aggregation was found to be positively
correlated with the N/P ratio applied, indicating that free
polymer contributes to erythrocyte aggregation (36,37).
The extent of polyplex-induced erythrocyte aggregation
correlated with the toxicity observed after intravenous
administration of the different p(DMAEA)-ppz polyplexes
in mice. Tail-vein administration of polyplexes of the starting
polymer or the high molecular weight polymers ppz950 and
ppz570 was limited to those with N/P ratios of 6 and lower, as
lethal toxicity occurred at higher N/P ratios. Remarkably,
polyplexes based on the lower molecular weight polymers
ppz290 and ppz130 could be administered at two to three fold
higher N/P ratios (12 and 20) without causing any apparent
toxicity. Polyplex-induced erythrocyte aggregation and sub-
sequent capillary occlusion is the likely mechanism linking
polymer molecular weight and in vivo toxicity. An associa-
tion between polymer molecular weight, erythrocyte aggre-
gation and toxicity after intravenous administration has been
suggested earlier for PEI polyplexes (38).
In Vivo Transfection
Tumor and organ gene expression was studied, 24 h after
administration of the polyplexes into the tail vein of tumor-
bearing mice (N/P ratio of 12 and 20). As a result of occurring
toxicity (see safety aspects), gene expression mediated by
polyplexes based on the starting polymer and the high
Fig. 7. Effect of ionic strength on the in vitro transfection activity of
DNA/p(DMAEA)-ppz complexes. Transfection values of polyplexes
based on the starting polymer, prepared at high ionic strength (HBS)
relative to values determined for polyplexes prepared at low ionic
strength (HBG), 24 h after transfection of Neuro 2 A cells (mean,
n=3).
Fig. 8. DNA/p(DMAEA)-ppz complex-induced erythrocyte aggregation (representative example at an N/P ratio of 12). Light microscopic
image of erythrocytes, after 1 h of incubation with polyplexes based on the starting polymer (a), ppz950 (b), ppz570 (c), ppz290 (d), ppz130 (e).
1578 de Wolf et al.molecular weight ppz950 and ppz570 could not be determined
at these N/P ratios. At a lower N/P ratio of 6, polyplexes of the
latter polymers did not show significant gene expression in any
of the organs. Possibly, the absence of gene expression is due
to the limited amount of polymer present, leading to complex
neutralization or complex dissociation after opsonization by
serumproteins(1,13). The administration of polyplexes of the
lower weight polymers (ppz290 and ppz130) resulted in
considerable tumor gene expression, when prepared at an N/P
ratio of 20 (Fig. 9a and b). However, gene expression was not
only confined to the tumor tissue, but was also observed in
liver and lung. At an N/P ratio of 12, intravenous administra-
tion of polyplexes based on the lowest molecular weight
polymer (ppz130) resulted in gene expression which was
confined to the tumor tissue. This tumor selective gene
expression is in good agreement with earlier findings on
p(DMAEA)ppz based polyplexes. The extent of luciferase
expression is similar to that observed for polyplexes based on
PEI22 (N/P 6) (5).
CONCLUSION
p(DMAEA)-ppz_s with different molecular weights
ranging from 130 to 950 kDa and with narrow molecular
weight distributions were obtained by size exclusion chroma-
tography. Polyplexes based on these polymers were prepared
and tested for biophysical properties, (cyto)toxicity, erythro-
cyte aggregation and in vitro and in vivo tumor transfection.
Polymer molecular weight affected many aspects impor-
tant in tumor transfection. By varying the polymer molecular
weight, we were able to optimize the transfection efficiency/
toxicity ratio of the p(DMAEA)-ppz polyplexes for in vitro
and in vivo tumor transfection. This study shows that in order
to obtain well-characterized polyplex transfection systems,
there is a need to use polymers with defined molecular weights
and narrow distributions.
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